← All comparisons
Head-to-head · FAERS comparison

Lamotrigine vs Carbamazepine: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

LamotrigineCarbamazepine
Drug classAnti-epileptic Agent, Mood StabilizerMood Stabilizer
Brand names––
FAERS reports130,96366,609
Serious72%86%
Death outcome11,2795,605
Boxed warningYes SERIOUS SKIN RASHES Lamotrigine can cause serious rashes requiring hospitalization and discontinuation of treatment. The incidence of these rashes, which have iYes SERIOUS DERMATOLOGIC REACTIONS AND HLA-B*1502 ALLELE SERIOUS AND SOMETIMES FATAL DERMATOLOGIC REACTIONS, INCLUDING TOXIC EPIDERMAL NECROLYSIS (TEN) AND STEVENS-

Signals both drugs share

ReactionLamotrigineCarbamazepineLabel screen (A / B)
Epilepsy3,415 · PRR 20.12,022 · PRR 22.3Labeled — boxed warning / Likely indication confounding
Petit mal epilepsy696 · PRR 25.3431 · PRR 29.1Labeled (related wording) / Likely indication confounding
Complex partial seizures173 · PRR 28.9160 · PRR 52.0Labeled (related wording) / Likely indication confounding
Simple partial seizures82 · PRR 17.865 · PRR 27.2Labeled (related wording) / Likely indication confounding
Change in seizure presentation86 · PRR 24.047 · PRR 24.2Labeled (related wording) / Likely indication confounding
Partial seizures with secondary generalisation81 · PRR 33.346 · PRR 34.2Labeled (related wording) / Likely indication confounding
Partial seizures548 · PRR 18.9390 · PRR 25.7Likely indication confounding / Likely indication confounding
Aura280 · PRR 28.2135 · PRR 24.6Not in label — unassessed / Not in label — unassessed
Myoclonic epilepsy210 · PRR 26.5125 · PRR 29.1Likely indication confounding / Likely indication confounding
Lip erosion225 · PRR 70.464 · PRR 29.9Not in label — unassessed / Not in label — unassessed
Focal dyscognitive seizures181 · PRR 30.0102 · PRR 30.8Likely indication confounding / Likely indication confounding
Sudden unexplained death in epilepsy170 · PRR 73.378 · PRR 53.0Likely indication confounding / Likely indication confounding
Atonic seizures114 · PRR 26.658 · PRR 24.6Likely indication confounding / Likely indication confounding

Labeled signals distinctive to Lamotrigine

Labeled signals distinctive to Carbamazepine

Common questions

Which has more reported side effects, Lamotrigine or Carbamazepine?

Lamotrigine has 130,963 FAERS reports and Carbamazepine 66,609. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (72% vs 86%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Lamotrigine and Carbamazepine share?

Both drugs carry disproportionality signals for epilepsy, petit mal epilepsy, complex partial seizures, simple partial seizures, change in seizure presentation. Shared signals often reflect a shared drug class or the condition both are used for.

Is Lamotrigine or Carbamazepine safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.